Novel inhibitors of HIF prolyl hydroxylase and their preclinical characterization

被引：0
|
作者：
Khristichenko, A. [1 ]
Smirnova, N. [1 ]
Andrey, O. [1 ]
Zakhariants, A. [2 ]
Gazaryan, I. [1 ]
Tonevitsky, A. [2 ]
Poloznikov, A. [1 ]
机构：
[1] Dmitry Rogachev Natl Res Ctr Pediat Hematol Oncol, Moscow, Russia
[2] Bioclinikum Res & Dev Ctr, Moscow, Russia
来源：
FEBS OPEN BIO | 2018年 / 8卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P.09-134-T
引用
收藏
页码：251 / 251
页数：1
相关论文
共 50 条
  • [21] A novel series of imidazo[1,2-a]pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors
    Warshakoon, Namal C.
    Wu, Shengde
    Boyer, Angelique
    Kawamoto, Richard
    Sheville, Justin
    Renock, Sean
    Xu, Kevin
    Pokross, Matthew
    Evdokimov, Artem G.
    Walter, Richard
    Mekel, Marlene
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5598 - 5601
  • [22] Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors:: SAR, synthesis, and modeling evaluation
    Tegley, Christopher M.
    Viswanadhan, Vellarkad N.
    Biswas, Kaustav
    Frohn, Michael J.
    Peterkin, Tanya A. N.
    Chang, Catherine
    Burli, Roland W.
    Dao, Jennifer H.
    Veith, Henrike
    Rogers, Norma
    Yoder, Sean C.
    Biddlecome, Gloria
    Tagari, Philip
    Allen, Jennifer R.
    Hungate, Randall W.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 3925 - 3928
  • [23] Inhibitors of HIF Prolyl Hydroxylases
    Rabinowitz, Michael H.
    Barrett, Terrance D.
    Rosen, Mark D.
    Venkatesan, Hariharan
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 123 - 139
  • [24] Letter in Response to "HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety"
    Yamamoto, Hiroyasu
    Nobori, Kiyoshi
    Matsuda, Yoshimi
    Hayashi, Yasuhiro
    Hayasaki, Takanori
    Akizawa, Tadao
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2022, 52 (12) : 977 - 978
  • [25] HIF2 ODD-luciferase reporter: the most sensitive assay for HIF prolyl hydroxylase inhibitors
    N. A. Smirnova
    A. I. Osipyants
    A. Yu. Khristichenko
    D. M. Hushpulian
    S. V. Nikulin
    T. A. Chubar
    A. A. Zakhariants
    V. I. Tishkov
    I. G. Gazaryan
    A. A. Poloznikov
    [J]. Russian Chemical Bulletin, 2018, 67 : 150 - 156
  • [26] HIF2 ODD-luciferase reporter: the most sensitive assay for HIF prolyl hydroxylase inhibitors
    Smirnova, N. A.
    Osipyants, A. I.
    Khristichenko, A. Yu.
    Hushpulian, D. M.
    Nikulin, S. V.
    Chubar, T. A.
    Zakhariants, A. A.
    Tishkov, V. I.
    Gazaryan, I. G.
    Poloznikov, A. A.
    [J]. RUSSIAN CHEMICAL BULLETIN, 2018, 67 (01) : 150 - 156
  • [27] Design and synthesis of substituted pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors
    Warshakoon, Namal C.
    Wu, Shengde
    Boyer, Angelique
    Kawamoto, Richard
    Sheville, Justin
    Bhatt, Ritu Tiku
    Renock, Sean
    Xu, Kevin
    Pokross, Matthew
    Zhou, Songtao
    Walter, Richard
    Mekel, Marlene
    Evdokimov, Artem G.
    East, Stephen
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5616 - 5620
  • [28] Azole derivatives as novel non-iron-chelating inhibitors of prolyl hydroxylase 3 for HIF-1 activation
    Cao, Jing
    Ma, Xiaoyan
    Wang, Xiaoxin
    Wang, Xiaobo
    Zhang, Zhong
    Geng, Zhirong
    Wang, Zhilin
    [J]. MEDCHEMCOMM, 2013, 4 (09) : 1222 - 1230
  • [29] UPLC-MS-Based Procedures to Detect Prolyl-Hydroxylase Inhibitors of HIF in Urine
    Mazzarino, Monica
    Perretti, Ilaria
    Stacchini, Carlotta
    Comunita, Fabio
    de la Torre, Xavier
    Botre, Francesco
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2021, 45 (02) : 184 - 194
  • [30] Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors
    Francesco Locatelli
    Roberto Minutolo
    Luca De Nicola
    Lucia Del Vecchio
    [J]. Drugs, 2022, 82 : 1565 - 1589
12345